How could I have missed that! Pricing doesn't matter. What a novel concept. What you know is that reimbursements have dropped by almost 75 percent for these drugs. That shouldn't have any impact at all on PXYN. (LOL)
Find the reason why MESA went public via PAWS shell and started off with over 12M in paper losses and the playing field will open up for you.
A/S and O/S will continue to escalate here. Take profits when they present themselves. Don't get emotionally tied to a story or a stock. Just make money alongside the OTC crooks and be happy.
News 
Market Data 
Discover 
AI
